Felicia D. Allard

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Associate Professor

University of Arkansas primary UA Little Rock UAMS

Also affiliated: Boston University (2010); Beth Israel Deaconess Medical Center (2013–2016); Harvard University (2014–2016); Oklahoma City University (2017); Hadassah Medical Center (2013); Stony Brook University Hospital (2021); Stony Brook School (2020–2022); Rocky Mountain MS Center (2010); Arkansas Department of Agriculture (2019); University of Oklahoma Health Sciences Center (2018–2023); University of Virginia (2016–2019); University of Colorado Anschutz Medical Campus (2010); Stony Brook University (2020–2022); University of Oklahoma (2017)

Faculty Researcher

14 h-index 59 pubs 659 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Felicia D. Allard investigates cancer biology and treatment response, with a focus on pancreatic ductal adenocarcinoma. Her recent work has identified Keratin 17 as a prognostic and predictive biomarker for this cancer, exploring its role in predicting chemotherapy response and modulating the tumor's immune environment. Allard also studies liver metabolism, examining the roles of pyruvate and alanine in maintaining antioxidant capacity and the protective effects of exogenous phosphatidic acid against acetaminophen-induced liver injury in mice. Her research extends to medical imaging analysis, including predicting pathologist visual attention when evaluating whole slide images of cancer. She has published 59 papers, accumulating 630 citations, and holds an h-index of 14. Allard collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including Eric U. Yee (13 shared publications) and Mitchell R. McGill (4 shared publications).

Metrics

h-index: 14
Publications: 59
Citations: 659

Selected Publications

Porto Sinusoidal Vascular Disorder Manifesting as Diffuse Arterio-Portal Fistulae and Portal Hypertension After Donation-After-Circulatory-Death Liver Transplantation (2026)

ACG Case Reports Journal DOI OpenAlex
Entrustable professional activities for cytopathology fellowship (2024)

Journal of the American Society of Cytopathology 1 citation DOI OpenAlex
Keratin 17 modulates the immune topography of pancreatic cancer (2024)

Journal of Translational Medicine 4 citations DOI OpenAlex
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma (2024)

American Journal of Clinical Pathology 8 citations DOI OpenAlex
Keratin 17 modulates the immune topography of pancreatic cancer (2024)

Research Square DOI OpenAlex
Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult (2023)

Molecular Metabolism 28 citations DOI OpenAlex
Keratin 17 as a Predictor of Chemotherapy Response in Pancreatic Ductal Adenocarcinoma (2023)

SSRN Electronic Journal 2 citations DOI OpenAlex
Cytology of Sinonasal Tract Lesions/Tumors (2023)

DOI OpenAlex
Predicting the Visual Attention of Pathologists Evaluating Whole Slide Images of Cancer (2022)

Lecture notes in computer science 4 citations DOI OpenAlex
Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult in mice (2022)

bioRxiv (Cold Spring Harbor Laboratory) 2 citations DOI OpenAlex
Radiation Effects on Methamphetamine Pharmacokinetics and Pharmacodynamics in Rats (2022)

European Journal of Drug Metabolism and Pharmacokinetics 3 citations DOI OpenAlex
Utility of the Fat Pad Fine-Needle Aspiration for Systemic Amyloidosis - A Retrospective Review of 110 Samples with Follow-up Studies (2020)

Journal of the American Society of Cytopathology DOI OpenAlex
Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease (2020)

Inflammatory Bowel Diseases 15 citations DOI OpenAlex
Endoscopic resection of a giant duodenal mass (2020)

Endoscopy DOI OpenAlex
Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease (2020)

bioRxiv (Cold Spring Harbor Laboratory) 2 citations DOI OpenAlex